Biblio Discovery — Demo Discovery Service

13 hasil untuk "Michael S. Cookson"

Menampilkan 1–13 · 0,86 detik · RSS

  1. Artikel Jurnal Teks lengkap

    The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer

    Daniel C. Parker; Michael S. Cookson

    Investigative and Clinical Urology, Vol. 61 No. S1 · 2020 · Inggris · DOAJ Scopus

    Metastatic prostate cancer is a heterogeneous disease entity. Men without prior androgen deprivation therapy exposure are termed metastatic castration sensitive prostate cancer (mCSPC). The goal of this article is to update the reader on the rapidly changing landscape of treatment for men with…

  2. Artikel Jurnal

    Bladder Cancer Recovery Pathways: A Systematic Review

    Ian Maloney; Daniel C. Parker; Michael S. Cookson dkk.

    Bladder Cancer, Vol. 3 · 2017 · Inggris · DOAJ Scopus

    Background: Enhanced recovery pathways, also known as fast-track protocols, have been adopted since the early 2000s by various surgical specialties with the goal of improving patient outcomes and reducing the cost burden of major surgery on the health care system. Objective: To review the…

  3. Artikel Jurnal

    Urothelial Carcinoma of the Bladder Metastatic to Bone Marrow Presenting as Isolated Thrombocytopenia

    Robert C. Chan; Greg L. Hundemer; Amy Tatsas dkk.

    The Scientific World Journal, Vol. 7 · 2007 · Inggris · DOAJ Scopus

    The skeletal system is a frequent site for metastases of urothelial carcinoma (UC) of the bladder (22–37%). Of those cases involving bone, the marrow is infiltrated in 27% of patients. Imaging modalities, such as X-ray and CT, will detect gross skeletal lesions in the vast majority of these…

  4. Artikel Jurnal Teks lengkap

    Advances in diagnosis and treatment of bladder cancer

    Antonio López-Beltrán; Michael S. Cookson; Brendan John Guercio dkk.

    BMJ · 2024 · Inggris · OpenAlex Scopus

    Bladder cancer remains a leading cause of cancer death worldwide and is associated with substantial impacts on patient quality of life, morbidity, mortality, and cost to the healthcare system. Gross hematuria frequently precedes the diagnosis of bladder cancer. Non-muscle-invasive bladder cancer…

  5. Artikel Jurnal

    Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma of the bladder

    Michael S. Cookson; Sam S. Chang; Christine Lihou dkk.

    Therapeutic Advances in Urology, Vol. 6 · 2014 · Inggris · DOAJ Scopus

    Objectives: The objective was to conduct a US multicenter, retrospective medical record study examining the effectiveness, safety, and patterns of use of valrubicin for treatment of nonmuscle-invasive bladder cancer (NMIBC) by clinicians since the 2009 reintroduction of valrubicin. Methods…

  6. Artikel Jurnal Teks lengkap

    Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

    Neal D. Shore; Fred Saad; Michael S. Cookson dkk.

    New England Journal of Medicine · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: Injectable luteinizing hormone-releasing hormone agonists (e.g., leuprolide) are the standard agents for achieving androgen deprivation for prostate cancer despite the initial testosterone surge and delay in therapeutic effect. The efficacy and safety of relugolix, an oral…

  7. Artikel Jurnal

    8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer

    William D. Dupont; Joan P. Breyer; W. Dale Plummer dkk.

    Nature Communications, Vol. 11 No. 1 · 2020 · Inggris · DOAJ Scopus

    Inherited alterations of the 8q24 genomic locus are linked to cancer etiology. Here, the authors investigate hereditary prostate cancer to reveal ancestral risk-altering haplotypes, the sentinel genetic variants optimally predicting risk, and causal mutation candidates.

  8. Artikel Jurnal Teks lengkap

    Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation

    David J. DeGraff; Peter E. Clark; Justin M. Cates dkk.

    PLoS ONE, Vol. 7 No. 5 · 2012 · Inggris · PLOS Scopus

    Approximately 50% of patients with muscle-invasive bladder cancer (MIBC) develop metastatic disease, which is almost invariably lethal. However, our understanding of pathways that drive aggressive behavior of MIBC is incomplete. Members of the FOXA subfamily of transcription factors are implicated…

    Juga tersedia di: DOAJ

  9. Artikel Jurnal Teks lengkap

    Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

    Veda N. Giri; Karen E. Knudsen; William Kevin Kelly dkk.

    Journal of Clinical Oncology · 2020 · Inggris · OpenAlex Scopus

    PURPOSE Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary cancer assessment. Critical needs include optimized multigene testing strategies that incorporate evolving genetic data, consistency in GT indications and management, and alternate…

  10. Artikel Jurnal Teks lengkap

    Perioperative Blood Transfusion Is Associated with Worse Survival in Patients Undergoing Radical Cystectomy after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

    Tessa Ladner; Anna J. Black; Homayoun Zargar dkk.

    Société Internationale d’Urologie Journal, Vol. 5 No. 3 · 2024 · Inggris · DOAJ

    Objectives: Perioperative blood transfusion (PBT) has been associated with worse survival after radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC). Here, we evaluated the association between PBT and survival after RC that was preceded by neoadjuvant chemotherapy (NAC)…

  11. Artikel Jurnal

    Genetic factors associated with prostate cancer conversion from active surveillance to treatment

    Yu Jiang; Travis J. Meyers; Adaeze A. Emeka dkk.

    HGG Advances, Vol. 3 No. 1 · 2022 · Inggris · DOAJ Scopus

    Summary: Men diagnosed with low-risk prostate cancer (PC) are increasingly electing active surveillance (AS) as their initial management strategy. While this may reduce the side effects of treatment for PC, many men on AS eventually convert to active treatment. PC is one of the most heritable…